Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same ho ...

A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...

USA: The findings from a recent retrospective cohort study involving 3,389 patients with obesity revealed the effectiveness ...

For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication ...

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...

And in this multivariable analysis, we saw that there are key predictors of achieving 10% or more weight loss, including patients who received semaglutide versus liraglutide, patients who received ...